HN1997000013A - Compuestos 1,4 dihidropiridina - Google Patents

Compuestos 1,4 dihidropiridina

Info

Publication number
HN1997000013A
HN1997000013A HN1997000013A HN1997000013A HN1997000013A HN 1997000013 A HN1997000013 A HN 1997000013A HN 1997000013 A HN1997000013 A HN 1997000013A HN 1997000013 A HN1997000013 A HN 1997000013A HN 1997000013 A HN1997000013 A HN 1997000013A
Authority
HN
Honduras
Prior art keywords
dihydropyridine
compounds
present
invention refers
refers
Prior art date
Application number
HN1997000013A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1997000013A publication Critical patent/HN1997000013A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Abstract

LA PRESENTE INVENCION SE REFIERE A :
HN1997000013A 1996-02-19 1997-01-27 Compuestos 1,4 dihidropiridina HN1997000013A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9600132 1996-02-19

Publications (1)

Publication Number Publication Date
HN1997000013A true HN1997000013A (es) 1997-06-26

Family

ID=11004406

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1997000013A HN1997000013A (es) 1996-02-19 1997-01-27 Compuestos 1,4 dihidropiridina

Country Status (34)

Country Link
US (1) US6131226A (es)
EP (1) EP0882044B1 (es)
JP (1) JP3167335B2 (es)
KR (1) KR19990082678A (es)
CN (1) CN1211251A (es)
AR (1) AR005841A1 (es)
AT (1) ATE220676T1 (es)
AU (1) AU1396497A (es)
BG (1) BG102678A (es)
BR (1) BR9707568A (es)
CA (1) CA2245857C (es)
CO (1) CO4650041A1 (es)
CZ (1) CZ258698A3 (es)
DE (1) DE69714019T2 (es)
DK (1) DK0882044T3 (es)
ES (1) ES2177921T3 (es)
HN (1) HN1997000013A (es)
HR (1) HRP970094A2 (es)
HU (1) HUP9902810A3 (es)
ID (1) ID16434A (es)
IL (1) IL124867A0 (es)
IS (1) IS4783A (es)
MA (1) MA26419A1 (es)
NO (1) NO983776D0 (es)
NZ (1) NZ325455A (es)
OA (1) OA10712A (es)
PE (1) PE36298A1 (es)
PL (1) PL328514A1 (es)
PT (1) PT882044E (es)
SI (1) SI0882044T1 (es)
TN (1) TNSN97037A1 (es)
TR (1) TR199801593T2 (es)
WO (1) WO1997030048A1 (es)
ZA (1) ZA971357B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11106375A (ja) * 1997-08-18 1999-04-20 Pfizer Pharmaceut Inc ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
GB0427281D0 (en) * 2004-12-14 2005-01-12 3M Innovative Properties Co Methods of providing medicinal metal components having through holes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120750A (en) * 1989-01-17 1992-06-09 Synphar Laboratories, Inc. Generation of 1,4-dihydropyridine derivatives
WO1996006083A1 (en) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists
MX9701245A (es) * 1996-02-19 1998-04-30 Pfizer Compuestos de 1,4 dihidropiridina.

Also Published As

Publication number Publication date
MA26419A1 (fr) 2004-12-20
DE69714019D1 (de) 2002-08-22
NZ325455A (en) 1999-07-29
OA10712A (en) 2001-06-04
JPH11507949A (ja) 1999-07-13
ES2177921T3 (es) 2002-12-16
NO983776L (no) 1998-08-18
DK0882044T3 (da) 2002-09-02
BG102678A (en) 1999-04-30
KR19990082678A (ko) 1999-11-25
WO1997030048A1 (en) 1997-08-21
DE69714019T2 (de) 2002-11-14
AR005841A1 (es) 1999-07-14
EP0882044B1 (en) 2002-07-17
JP3167335B2 (ja) 2001-05-21
TR199801593T2 (xx) 1999-12-21
PE36298A1 (es) 1998-07-18
PT882044E (pt) 2002-11-29
CA2245857C (en) 2002-10-01
HUP9902810A2 (hu) 2000-05-28
IL124867A0 (en) 1999-01-26
CN1211251A (zh) 1999-03-17
ATE220676T1 (de) 2002-08-15
IS4783A (is) 1998-06-25
CO4650041A1 (es) 1998-09-03
HRP970094A2 (en) 1998-06-30
HUP9902810A3 (en) 2000-09-28
ZA971357B (en) 1998-08-18
NO983776D0 (no) 1998-08-18
TNSN97037A1 (fr) 2005-03-15
AU1396497A (en) 1997-09-02
SI0882044T1 (en) 2002-10-31
CZ258698A3 (cs) 1999-06-16
ID16434A (id) 1997-09-25
CA2245857A1 (en) 1997-08-21
BR9707568A (pt) 1999-07-27
EP0882044A1 (en) 1998-12-09
US6131226A (en) 2000-10-17
PL328514A1 (en) 1999-02-01

Similar Documents

Publication Publication Date Title
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1997000090A (es) Compuestos de piridilpirrol
HN1997000023A (es) Derivados de lactama
HN1998000175A (es) Imidazotriazininas
HN1998000057A (es) Derivados de nicotinamida
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
HN1997000097A (es) Piridinas condensadas con heterociclicos
HN1997000126A (es) Derivados de indazol
HN1998000036A (es) Compuesto de pirazina
HN1997000166A (es) 1-arilpirazoles plaguicidas
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
CY2007024I2 (el) Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων
HN1996000124A (es) 2-ox y 2- tio - 1, 2 dihidroquinolinil oxazolidinonas
HN1997000149A (es) Derivados de 6 fenilpiridil 2 amina
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998003689A (es) Azetidinas
HN1998000124A (es) Terapia de combinacion
HN1998000158A (es) Isoquinolinas
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
HN1998000028A (es) Otropisomeros de 3 heteroaril - 4 (3h) - quinazolinonas.
HN1997000045A (es) Nuevos pirimido (1, 2 - 0) indoles
HN1998000045A (es) Composiciones farmaceuticas
HN1998000193A (es) Compuestos de triazina
HN1998000102A (es) Composiciones solubilizadas de sertralina